IL41610A - Antihypertensive compositions containing hydralazine and a 3-(1,2,5-thiadiazol-3-yloxy)-2-propanolamine derivative beta-adrenergic blocking agent - Google Patents

Antihypertensive compositions containing hydralazine and a 3-(1,2,5-thiadiazol-3-yloxy)-2-propanolamine derivative beta-adrenergic blocking agent

Info

Publication number
IL41610A
IL41610A IL41610A IL4161073A IL41610A IL 41610 A IL41610 A IL 41610A IL 41610 A IL41610 A IL 41610A IL 4161073 A IL4161073 A IL 4161073A IL 41610 A IL41610 A IL 41610A
Authority
IL
Israel
Prior art keywords
thiadiazol
yloxy
compositions containing
blocking agent
adrenergic blocking
Prior art date
Application number
IL41610A
Other languages
English (en)
Other versions
IL41610A0 (en
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of IL41610A0 publication Critical patent/IL41610A0/xx
Publication of IL41610A publication Critical patent/IL41610A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/10—1,2,5-Thiadiazoles; Hydrogenated 1,2,5-thiadiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL41610A 1972-03-06 1973-02-26 Antihypertensive compositions containing hydralazine and a 3-(1,2,5-thiadiazol-3-yloxy)-2-propanolamine derivative beta-adrenergic blocking agent IL41610A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US00232294A US3833727A (en) 1972-03-06 1972-03-06 Hydralazine and beta-adrenergic blocking agent compositions for treating hypertension

Publications (2)

Publication Number Publication Date
IL41610A0 IL41610A0 (en) 1973-04-30
IL41610A true IL41610A (en) 1975-08-31

Family

ID=22872572

Family Applications (1)

Application Number Title Priority Date Filing Date
IL41610A IL41610A (en) 1972-03-06 1973-02-26 Antihypertensive compositions containing hydralazine and a 3-(1,2,5-thiadiazol-3-yloxy)-2-propanolamine derivative beta-adrenergic blocking agent

Country Status (19)

Country Link
US (1) US3833727A (xx)
AT (1) AT331966B (xx)
BE (1) BE796288A (xx)
CA (1) CA1015662A (xx)
CY (1) CY951A (xx)
DD (1) DD103559A5 (xx)
FR (1) FR2181786B1 (xx)
GB (1) GB1385648A (xx)
HK (1) HK23378A (xx)
HU (1) HU165714B (xx)
IE (1) IE37326B1 (xx)
IL (1) IL41610A (xx)
KE (1) KE2839A (xx)
LU (1) LU67144A1 (xx)
MY (1) MY7800295A (xx)
NL (1) NL176746C (xx)
PH (1) PH18901A (xx)
SE (1) SE400472B (xx)
ZA (1) ZA731505B (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4001421A (en) * 1971-10-27 1977-01-04 Syntex (U.S.A.) Inc. Thiazole cardiovascular agents
AU540656B2 (en) * 1980-02-19 1984-11-29 Merck & Co., Inc. S-(-)-1-(tert-butylamino-3((4-morpholino-1,2,5-thiadiazol-3- yl)-oxy)-2-propanol pamoate
US4521414A (en) * 1981-06-18 1985-06-04 The Texas A&M University System Ophthalmic compositions and their use for treating elevated intraocular pressure and glaucoma
US20110092507A1 (en) * 2009-10-20 2011-04-21 Chin-Tsai Fan Process for preparing R-(+)-3-morpholino-4-(3- tert-butylamino-2-hydroxypropoxy)-1,2,5-thiadiazole

Also Published As

Publication number Publication date
AT331966B (de) 1976-09-10
US3833727A (en) 1974-09-03
KE2839A (en) 1978-05-26
DE2310836B2 (de) 1976-11-04
CA1015662A (en) 1977-08-16
AU5266273A (en) 1974-08-29
FR2181786A1 (xx) 1973-12-07
BE796288A (fr) 1973-09-05
NL176746B (nl) 1985-01-02
IE37326L (en) 1973-09-06
GB1385648A (en) 1975-02-26
PH18901A (en) 1985-10-30
DD103559A5 (xx) 1974-02-05
IE37326B1 (en) 1977-06-22
ZA731505B (en) 1974-10-30
CY951A (en) 1978-12-22
IL41610A0 (en) 1973-04-30
HK23378A (en) 1978-05-12
HU165714B (xx) 1974-10-28
SE400472B (sv) 1978-04-03
DE2310836A1 (de) 1973-09-20
NL7302728A (xx) 1973-09-10
FR2181786B1 (xx) 1976-05-14
NL176746C (nl) 1985-06-03
MY7800295A (en) 1978-12-31
ATA195873A (de) 1975-12-15
LU67144A1 (xx) 1973-09-06

Similar Documents

Publication Publication Date Title
NZ183616A (en) Acetohydroxamic derivatives,and pharmaceutical compositions
ZA733143B (en) 2,1,3-benzothiadiazole derivatives
PH9682A (en) 1,2,3,4-tetrahydro-4-phenyl-isoquinoline derivatives and pharmaceutical composition containing same
IL39391A (en) 1,3,4-thiadiazol-2-yl-imidazolidinone-(2)derivatives,their preparation and herbicidal compositions containing them
GB1519689A (en) 4,5-dhydro 2 - lower - alkoxycarbonylamino - 4 - phenylimidazoles and substituted phenyl derivatives thereof
IL51339A (en) 3-(substituted)methylene-4-oxa-1-azabicyclo(3.2.0)heptan-7-one derivatives their preparation and pharmaceutical compositions containing them
PH12918A (en) 1,3-dioxo-2-aminoalkyl-4,4-dimethyl-isoquinolines and salts thereof
IL43840A0 (en) New derivatives of 1,3,4-oxadiazole and fungicidal compositions containing them
ZA757510B (en) 8,8-disubstituted-6-methylergolines and related compounds
IL41009A (en) Antibacterial compositions containing rifamicin and a 2,4-diamino-5-benzylpyrimidine derivative
IL41610A (en) Antihypertensive compositions containing hydralazine and a 3-(1,2,5-thiadiazol-3-yloxy)-2-propanolamine derivative beta-adrenergic blocking agent
NZ185539A (en) Cis-4a-aryl-2-substituted-2,3,4,4a,5,6,7,7a-octa hydro-1h-2-pyrindines and pharmaceutical compositions
NZ184185A (en) 3,5,5-trimethylhexanoyl-ferrocene and pharmaceutical compositions
IL40227A0 (en) 1,3-dioxanes and herbicidal compositions containing them
NZ180657A (en) 3-aminoalkyl-2-phenyl-bicyclo (2.2.2)-octane or-oct-2-ene derivatives,and pharmaceutical compositions
PH11056A (en) 3-(i-alkyl-4 or 5-nitro-2-imidazolyl)-4-imidazoline 2 thiones and compositions thereof
NZ185996A (en) 6, 7-methylene-3-oxo-d-homo-17a-pregna-4, 16-dienes and pharmaceutical compositions
NZ182228A (en) -1,2,4-triazol-1-yl- -alkylcarbonyl-thiophenes and fungicidal compositions
NZ178645A (en) 2-amino-4-azido-6-formylamino-1,3,5-triazines and compositions
IL47111A (en) 3,4-dicarboxycephalosporins and derivatives
IL42363A0 (en) 1,2,4-oxadiazole derivatives
ZA721581B (en) 1,4,2-dioxazine derivatives
NZ185290A (en) 1,6-anhydro- -d-hexopyranose derivatives and pharmaceutical compositions
ZA756231B (en) Pharmaceutical compositions comprising substituted 3-cinnamoyl-2h-pyran-2.6(3h)-diones
IL38791A (en) 1,3,4,5-tetrahydro-2,3-benzoxazepine derivatives